K vs STOK · P/E 23, $29.03B cap vs rev $36.6M
Kellanova (K) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported STOK revenue for 2024-12-31 was $36.6M. Net income was -$89.0M. Revenue was up 316.3% from 2023-12-31 to 2024-12-31. STOK currently screens at market cap $1.88B.
K currently screens at market cap $29.03B and trailing P/E 22.8. STOK currently screens at market cap $1.88B.
Not investment advice. Open the K and STOK stock pages for the full models.
Not investment advice.